Cargando…
Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma
SIMPLE SUMMARY: Diffuse large B cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). Despite the genetic heterogeneity of the disease, most patients are initially treated with a combination of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP), but...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125500/ https://www.ncbi.nlm.nih.gov/pubmed/33946435 http://dx.doi.org/10.3390/cancers13092167 |